Update on Clinical Trials in Systemic Lupus Erythematosus

Sonali Narain; Richard Furie

Disclosures

Curr Opin Rheumatol. 2016;28(5):477-487. 

In This Article

Targeting Interferons

Type I IFNs have long been implicated in the pathogenesis of SLE.[66,67] Therapeutic targets have included IFNα, IFNα receptor and IFNγ. Key trials are illustrated in Table 3.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....